Evolus, INC. (EOLS) — 8-K Filings

8-K Filings (10)

• Evolus Appoints New Directors, Sees Director Departure — Sep 8, 2025 Risk: low
  Evolus, Inc. announced on September 8, 2025, the departure of director Dr. David L. R. Alston. The company also announced the election of two new directors, Dr.
• Evolus CFO Departs, Interim Appointed; New Directors Elected — Jun 6, 2025 Risk: medium
  Evolus, Inc. announced on June 5, 2025, the departure of its Chief Financial Officer, Michael J. MacIntyre, effective June 14, 2025. The company also appointed
• Evolus Appoints New Directors, One Departs — May 27, 2025 Risk: low
  Evolus, Inc. announced on May 23, 2025, the departure of director Dr. David L. Brown. The company also elected two new directors, Dr. Jeffrey L. Blount and Ms.
• Evolus, Inc. Enters Material Agreement, Incurs Financial Obligation — May 5, 2025 Risk: medium
  Evolus, Inc. announced on May 5, 2025, the entry into a material definitive agreement and the creation of a direct financial obligation. The company also made a
• Evolus, Inc. Files 8-K on Financials — Jan 21, 2025 Risk: low
  Evolus, Inc. filed an 8-K on January 21, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and
• Evolus Appoints New CMO, Elects Director — Jul 1, 2024 Risk: low
  Evolus, Inc. announced on July 1, 2024, the appointment of Dr. David J. Stark as Chief Medical Officer and the election of Ms. Sarah E. Gleason to its Board of
• Evolus Announces CFO Departure, New CMO & Board Members — Jun 11, 2024 Risk: medium
  Evolus, Inc. announced on June 6, 2024, the departure of its Chief Financial Officer, Michael J. MacBride, effective June 14, 2024. The company also appointed D
• Evolus Appoints New Chief Medical Officer — Apr 3, 2024 Risk: low
  Evolus, Inc. announced on April 2, 2024, the appointment of Dr. David J. Stark as Chief Medical Officer and Executive Vice President, effective April 1, 2024. D
• Evolus, Inc. Signs Material Definitive Agreement — Mar 13, 2024 Risk: medium
  Evolus, Inc. announced on March 11, 2024, that it entered into a material definitive agreement. The company, headquartered in Newport Beach, California, filed a
• Evolus 8-K Details Operations & Financial Condition — Jan 16, 2024
  Evolus, Inc. filed an 8-K on January 16, 2024, reporting on 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits.' This filing

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX